Pharmacokinetic interaction study [Regulatives / Guidelines]

posted by nobody – 2016-05-20 11:40 (3333 d 00:48 ago) – Posting: # 16343
Views: 3,594

I would support this opinion (at least for EU), as the EMA DDI Guideline as of 2012 does not require formal BE testing. Why should this be more rigid for new FDCs?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,684 registered users;
16 visitors (0 registered, 16 guests [including 9 identified bots]).
Forum time: 12:28 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5